TrialAnnals of oncology : official journal of the European Society for Medical Oncology2011

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

L Licitra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.